RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.35
-0.03 (-0.41%)
At close: Jul 18, 2025, 4:00 PM
7.35
0.00 (0.00%)
After-hours: Jul 18, 2025, 6:05 PM EDT

RxSight Statistics

Total Valuation

RxSight has a market cap or net worth of $298.68 million. The enterprise value is $81.38 million.

Market Cap298.68M
Enterprise Value 81.38M

Important Dates

The next confirmed earnings date is Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

RxSight has 40.64 million shares outstanding. The number of shares has increased by 11.26% in one year.

Current Share Class 40.64M
Shares Outstanding 40.64M
Shares Change (YoY) +11.26%
Shares Change (QoQ) +0.38%
Owned by Insiders (%) 5.31%
Owned by Institutions (%) 76.58%
Float 29.59M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.97
Forward PS 1.80
PB Ratio 1.07
P/TBV Ratio 1.07
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.55
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.68, with a Debt / Equity ratio of 0.04.

Current Ratio 12.68
Quick Ratio 11.45
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,755.33

Financial Efficiency

Return on equity (ROE) is -11.98% and return on invested capital (ROIC) is -10.06%.

Return on Equity (ROE) -11.98%
Return on Assets (ROA) -9.29%
Return on Invested Capital (ROIC) -10.06%
Return on Capital Employed (ROCE) -12.70%
Revenue Per Employee $297,811
Profits Per Employee -$53,303
Employee Count498
Asset Turnover 0.60
Inventory Turnover 1.97

Taxes

In the past 12 months, RxSight has paid $59,000 in taxes.

Income Tax 59,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.46% in the last 52 weeks. The beta is 1.21, so RxSight's price volatility has been higher than the market average.

Beta (5Y) 1.21
52-Week Price Change -84.46%
50-Day Moving Average 13.29
200-Day Moving Average 28.88
Relative Strength Index (RSI) 20.74
Average Volume (20 Days) 2,015,069

Short Selling Information

The latest short interest is 5.79 million, so 14.25% of the outstanding shares have been sold short.

Short Interest 5.79M
Short Previous Month 4.96M
Short % of Shares Out 14.25%
Short % of Float 19.57%
Short Ratio (days to cover) 5.96

Income Statement

In the last 12 months, RxSight had revenue of $148.31 million and -$26.55 million in losses. Loss per share was -$0.67.

Revenue148.31M
Gross Profit 106.59M
Operating Income -36.86M
Pretax Income -36.75M
Net Income -26.55M
EBITDA -33.63M
EBIT -36.86M
Loss Per Share -$0.67
Full Income Statement

Balance Sheet

The company has $229.34 million in cash and $12.04 million in debt, giving a net cash position of $217.30 million or $5.35 per share.

Cash & Cash Equivalents 229.34M
Total Debt 12.04M
Net Cash 217.30M
Net Cash Per Share $5.35
Equity (Book Value) 279.32M
Book Value Per Share 6.88
Working Capital 265.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.47 million and capital expenditures -$4.05 million, giving a free cash flow of -$20.52 million.

Operating Cash Flow -16.47M
Capital Expenditures -4.05M
Free Cash Flow -20.52M
FCF Per Share -$0.50
Full Cash Flow Statement

Margins

Gross margin is 71.87%, with operating and profit margins of -24.85% and -17.90%.

Gross Margin 71.87%
Operating Margin -24.85%
Pretax Margin -17.86%
Profit Margin -17.90%
EBITDA Margin -22.67%
EBIT Margin -24.85%
FCF Margin n/a

Dividends & Yields

RxSight does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.26%
Shareholder Yield -11.26%
Earnings Yield -8.89%
FCF Yield -6.87%
Dividend Details

Analyst Forecast

The average price target for RxSight is $18.45, which is 151.02% higher than the current price. The consensus rating is "Hold".

Price Target $18.45
Price Target Difference 151.02%
Analyst Consensus Hold
Analyst Count 12
Revenue Growth Forecast (5Y) 14.66%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RxSight has an Altman Z-Score of 30.47 and a Piotroski F-Score of 4.

Altman Z-Score 30.47
Piotroski F-Score 4